Compare Fastenal Company Common Stock (FAST) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fastenal Company Common Stock vs BIO-TECHNE Corp — how do they compare? Fastenal Company Common Stock trades at $50.72 (market cap $57.94B), while BIO-TECHNE Corp trades at $72.44 (market cap $11.36B). The key difference: Fastenal Company Common Stock is far larger — about 5.1× BIO-TECHNE Corp's market cap, and Fastenal Company Common Stock pays the higher dividend (1.9%). Which is the better fit depends on your goals — on Pluang, investors hold Fastenal Company Common Stock for 1 Days and BIO-TECHNE Corp for 64 Days on average.
| FAST | TECH | |
|---|---|---|
Market Cap | $57.94B | $11.36B |
Volume | 6,764,575 | 5,390,331 |
Sector | Industrials | Health |
52-Week High | $52.38 | $72.61 |
52-Week Low | $39.15 | $43.31 |
Typical Hold Time | 1 Days | 64 Days |
Enterprise Value | $58.17B | $11.39B |
Dividend Yield | 1.9% | 0.44% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fastenal Company Common Stock
Fastenal distributes fasteners, tools, safety supplies, and other industrial products. It also provides inventory management and vending solutions for business customers.
Read more on FAST →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
